A 5-Pathway Signature Predicts Prognosis Based on Immune-Derived lncRNAs in Patients with Breast Cancer.

Bo Liu,Nian Zhu,Huixia Huo,Junqi Long,Xinchan Ji,Jinmeng Li,Xujie Zhuang,Huina Wang,Lujia Li,Yuhaoran Chen,Wei Yang,Shuangtao Zhao

Journal of oncology（2022）

引用 1|浏览6

暂无评分

摘要

This 5-pathway signature correlated with immune-derived lncRNAs was able to precisely predict the prognosis for patients with BRCA and provided a rich source characterizing immune-related lncRNAs and further informed strategies to target BRCA vulnerabilities.

查看译文

关键词

lncrnas,breast cancer,immune-derived

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要